MicroRNA-155 (miR-155) is dysregulated in human cancers. In this study, we reported that miR-155 was over-expressed in bladder cancer tissues. We found that miR-155 promoted cell proliferation in vitro and tumorigenesis in vivo. MiR-155 directly reduced the expression of the tumor suppressor DMTF1. The expression of DMTF1 was decreased in bladder cancer tissues. Similar to the restoring miR-155 expression, knockdown of DMTF1 promoted cell growth and cell cycle progression, whereas DMTF1 over-expression rescued the effect of miR-155. Moreover, we investigated DMTF1-Arf-p53 pathway and found that DMTF1 worked in both p53-dependent and p53-independent manners. Taken together, our findings suggested that miR-155 functions as a tumor promoter in bladder cancer, which is partially through repressing DMTF1 expression. The identification of miR-155 and its novel target DMTF1 will be valuable in developing diagnostic markers and therapeutic applications for bladder cancer.
CITATION STYLE
Peng, Y., Dong, W., Lin, T. X., Zhong, G. Z., Liao, B., Wang, B., … Huang, J. (2015). MicroRNA-155 promotes bladder cancer growth by repressing the tumor suppressor DMTF1. Oncotarget, 6(18), 16043–16058. https://doi.org/10.18632/oncotarget.3755
Mendeley helps you to discover research relevant for your work.